Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will meet with Group B Strep Support to discuss the importance of (a) early and (b)consistent diagnosis of Group B Streptococcus.

Recruitment to the GBS3 trial ended in May 2024. The researchers are analysing the data, and a report is expected in Summer 2025. The UK National Screening Committee Secretariat is in close and regular contact with the researchers. The committee will review its recommendation, considering the evidence from the trial, once the report is available.

As part of this, the UK National Screening Committee will engage with stakeholders, in line with its usual processes.